Display Settings:

Format

Send to:

Choose Destination
    Brain Behav Immun. 2008 Nov;22(8):1197-200. Epub 2008 Jul 9.

    Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings.

    Source

    Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience and Human Behavior, USA.

    Abstract

    Converging evidence from basic and clinical studies suggests a role for proinflammatory cytokines in cancer-related fatigue, although the etiology of elevated inflammatory processes is unclear. We examined single nucleotide polymorphisms (SNPs) in the promoters of cytokine genes as genetic risk factors for cytokine-related fatigue in 33 fatigued and 14 non-fatigued breast cancer survivors, focusing on promoter sequence polymorphisms in IL1B and IL6 associated with differential expression of proinflammatory cytokines. Predictors of fatigue included presence of at least one cytosine at IL1B -511 (95%CI=0.91-16.6, p=.007) and homozygosity for either variant of the IL6 -174 genotype (G/G or C/C; 95%CI=1.12-17.9, p=.027). Associations between fatigue status and IL1B genotype remained significant after covariate adjustment for demographic, biobehavioral and treatment-related factors. These findings provide preliminary evidence that polymorphisms in IL1B may serve as a potential risk factor for persistent fatigue in the aftermath of cancer.

    PMID:
    18617366
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2783767
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Fig. 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk